Black Diamond Therapeutics Inc (BDTX) — Financial Flexibility Index
Black Diamond Therapeutics Inc (BDTX) has a Financial Flexibility Index of -0.25x as of June 2026. Free cash flow of $-7.14 Million (operating CF $-7.14 Million minus capex $0.00) represents 0% of total liabilities ($28.94 Million). Check total reinvestment intensity of Black Diamond Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Black Diamond Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Black Diamond Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see BDTX operating cash flow.
Annual Financial Flexibility Index for Black Diamond Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Black Diamond Therapeutics Inc. Explore BDTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $29.61 Million | $29.61 Million | $30.80 Million | ▲ +160.7% |
| 2024 | -1.58x | $-62.30 Million | $-62.30 Million | $39.35 Million | ▲ +0.7% |
| 2023 | -1.59x | $-66.68 Million | $-66.72 Million | $41.83 Million | ▲ +23.8% |
| 2022 | -2.09x | $-84.89 Million | $-85.08 Million | $40.56 Million | ▼ -11.2% |
| 2021 | -1.88x | $-97.44 Million | $-100.15 Million | $51.78 Million | ▲ +20.7% |
| 2020 | -2.37x | $-52.00 Million | $-52.15 Million | $21.91 Million | ▼ -1877.9% |
| 2019 | -0.12x | $-24.65 Million | $-24.67 Million | $205.45 Million | ▲ +3.5% |
| 2018 | -0.12x | $-8.38 Million | $-8.45 Million | $67.37 Million | ▲ +19.6% |
| 2017 | -0.15x | $-2.27 Million | $-2.35 Million | $14.70 Million | — |